These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37462048)

  • 1. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
    Ishimoto T; Yagi A; Nakajima K; Okamoto N; Yukimitsu E; Kawasaki M; Kawae Y; Hayasaka S; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2023 Aug; 19(2):2229222. PubMed ID: 37462048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
    Yagi A; Nakagawa S; Ueda Y; Oka E; Ikeda S; Kakuda M; Kobayashi E; Ito Y; Katayama K; Hirai K; Nakayama T; Kimura T
    Cancer Sci; 2024 Mar; 115(3):916-925. PubMed ID: 38158850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare's revised HPV vaccine leaflet.
    Shiomi M; Ueda Y; Abe H; Yagi A; Sakiyama K; Kimura T; Tanaka Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Matsumura N; Saito J; Takagi T; Horikoshi Y; Shimura K
    Hum Vaccin Immunother; 2020 Oct; 16(10):2555-2558. PubMed ID: 32243236
    [No Abstract]   [Full Text] [Related]  

  • 4. Intentions for catch-up HPV vaccination in Japan: an internet survey.
    Nakagawa S; Yagi A; Ueda Y; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kimura T; Hirai K; Sekine M; Nakayama T; Kobayashi E; Miyagi E; Enomoto T; Kimura T
    Int J Clin Oncol; 2023 Dec; 28(12):1667-1679. PubMed ID: 37776388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus Vaccination by Birth Fiscal Year in Japan.
    Yagi A; Ueda Y; Oka E; Nakagawa S; Kimura T
    JAMA Netw Open; 2024 Jul; 7(7):e2422513. PubMed ID: 39012629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
    Yagi A; Ueda Y; Oka E; Nakagawa S; Kimura T; Shimoya K
    Cancer Sci; 2024 Jul; 115(7):2410-2416. PubMed ID: 38698561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
    Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
    Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study.
    Machida M; Inoue S
    Vaccine; 2023 May; 41(18):2956-2960. PubMed ID: 37024410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives.
    Yagi A; Ueda Y; Kimura T
    Vaccine; 2024 Sep; 42(22):125859. PubMed ID: 38616440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program.
    Miyoshi A; Ueda Y; Yagi A; Kimura T; Kobayashi E; Hiramatsu K; Nakagawa S; Kimura T
    Hum Vaccin Immunother; 2021 Nov; 17(11):4418-4422. PubMed ID: 35016492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
    Yagi A; Ueda Y; Nakagawa S; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Mizushima T; Suzuki Y; Sekine M; Hirai K; Nakayama T; Miyagi E; Enomoto T; Kimura T
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year questionnaire study on human papillomavirus vaccination targeting new female college school students: Follow-up to a 2021 report to reveal the impact of a policy change in Japan.
    Furuno A; Sukegawa A; Ohshige K; Suzuki Y; Yamaguchi M; Miyagi E; Ueda Y; Sekine M; Mizushima T
    J Obstet Gynaecol Res; 2024 Sep; 50(9):1640-1648. PubMed ID: 39155400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
    Nakagawa S; Ueda Y; Yagi A; Ikeda S; Hiramatsu K; Kimura T
    Cancer Sci; 2020 Jun; 111(6):2156-2162. PubMed ID: 32248632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.
    Morimoto A; Ueda Y; Egawa-Takata T; Yagi A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Kanzaki H; Nakai H; Mandai M; Yoshino K; Fujita M; Kimura T; Saito J; Sobue T; Nishikawa N; Sekine M; Enomoto T; Horikoshi Y; Takagi T
    Int J Clin Oncol; 2015 Jun; 20(3):549-55. PubMed ID: 25001869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination.
    Egawa-Takata T; Ueda Y; Morimoto A; Yoshino K; Kimura T; Nishikawa N; Sekine M; Horikoshi Y; Takagi T; Enomoto T
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1965-71. PubMed ID: 26420072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemplating HPV vaccination in Japan during the time of COVID-19.
    Miyoshi A; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2021 Mar; 17(3):836-837. PubMed ID: 32961077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
    Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
    Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of future cervical cancer risk in Japan, based on birth year.
    Yagi A; Ueda Y; Ikeda S; Sekine M; Nakayama T; Miyagi E; Enomoto T
    Vaccine; 2019 May; 37(22):2889-2891. PubMed ID: 31027925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
    Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
    Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination: a 7-year follow-up survey in Japan.
    Oka E; Ueda Y; Nagase Y; Sawada M; Egawa-Takata T; Yagi A; Kakuda M; Nakagawa S; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Kimura T
    Int J Clin Oncol; 2022 Aug; 27(8):1356-1363. PubMed ID: 35525903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.